The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: A modelling study

Journal of Infectious Diseases

Volumn 210, Issue 12, 2014, Pages 1972-1980

  Slater, Hannah C ^a   Walker, Patrick G T ^a   Bousema, Teun ^b,c   Okell, Lucy C ^a   Ghani, Azra C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Ivermectin; Malaria; Mass drug administration; Mass screen and treat

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; IVERMECTIN; INSECTICIDE;

ANOPHELES GAMBIAE; ARTICLE; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MORTALITY; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITE VECTOR; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; DRUG EFFECTS; DRUG THERAPY; FEMALE; MALE; MIDDLE AGED; MOSQUITO; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; SURVIVAL; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; CULICIDAE; DRUG THERAPY; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; MALARIA; MALE; MIDDLE AGED; SURVIVAL; YOUNG ADULT;

EID: 84922440536     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu351     Document Type: Article

References (46)

1. Chaccour C, Kobylinski K, Bassat Q, et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malaria J 2013;12:153.
2. Foley DH, Bryan JH, Lawrence GW. The potential of ivermectin to control the malaria vector Anopheles farauti. Trans R Soc Trop Med Hyg 2000;94:625-8.
3. Chaccour C, Lines J, Whitty C J M. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. J Infect Dis 2010;202:113-6.
4. Bastiaens G J H, Gemert G-JV, Hooghof J, et al. Duration of the mosquitocidal effect of ivermectin. Malariaworld J 2012;3:1-5.
5. Bockarie MJ, Hii JL, Alexander ND, et al. Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival. Med Vet Entomol 1999;13:120-3.
6. Cartel JL, Sechan Y, Spiegel A, et al. Cumulative mortality rates in Aedes polynesiensis after feeding on Polynesian Wuchereria bancrofti carriers treated with single doses of ivermectin, diethylcarbamazine and placebo. Trop Med Parasitol (GTZ) 1991;42:343-5.
7. Fritz ML, Siegert PY, Walker ED, Bayoh MN, Vulule J R M JR. Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l. Ann Trop Med Parasitol 2009;103:539-47.
8. Gardner K, Meisch MV, Meek CL, Biven WS. Effects of ivermectin in canine blood on Anopheles quadrimaculatus, Aedes albopictus and Culex salinarius. J Am Mosq Control Assoc 1993;9:400-2.
9. Jones J, Meisch MV, Meek CL, Bivin WS. Lethal effects of ivermectin on Anopheles quadrimaculatus. J Am Mosq Control Assoc 1992;8:278-80.
10. Kobylinski KC, Deus KM, Butters MP, et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. Acta tropica 2010;116:119-26.
11. Kobylinski KC, Foy BD, Richardson JH. Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae. Malaria J 2012;11:381.
12. Sylla M, Kobylinski KC, Gray M, et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wildcaught, blood fed malaria vectors. Malaria J 2010;9:365.
13. Tesh RB, Guzman H. Mortality and infertility in adult mosquitoes after the ingestion of blood containing ivermectin. Am J Trop Med Hyg 1990;43:229-33.
14. Griffin JT, Hollingsworth TD, Okell LC, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLOS Med 2010;7:e1000324.
15. Kobylinski KC, Sylla M, Chapman PL, Sarr MD, Foy BD. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. Am J Trop Med Hyg 2011;85:3-5.
16. Pluess B, Tanser Frank C, Lengeler C, Sharp Brian L. Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev. John Wiley & Sons, Ltd, 2010.
17. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. John Wiley & Sons, Ltd, 2004.
18. Ranson H, N'Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol 2011;27:91-8.
19. Russell T, Govella N, Azizi S, Drakeley C, Kachur SP, Killeen G. Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania. Malaria J 2011;10:80.
20. Takken W. Do insecticide-treated bednets have an effect on malaria vectors? Trop Med Int Health 2002;7:1022-30.
21. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol 2003;19:452-60.
22. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Björkman A. Malaria eradication on islands. Lancet 2000;356:1560-4.
23. Tea L. Control of malaria in a river valley project. Bull Indian Soc Malaria and Other Communicable Di 1968;5:94-105.
24. Zulueta J, Kafuko GW, McCrae AW, Cullen JR, Pedrsen CK, Wasswa DF. A malaria eradication experiment in the highlands of Kigezi (Uganda). East African Med J 1964;41:102-20.
25. Singh M. Epidemiologic study of focal outbreak of malaria in consolidation phase area and evaluation of remedial measures in Uttar Pradesh (India). Bull Indian Soc Malaria and Other Communicable Di 1968;5:207-20.
26. Baraka OZ, Mahmoud BM, Marschke CK, Geary TG, Homeida M M A, Williams JF. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur J Clin Pharmacol 1996;50:407-10.
27. Krishna DR, Klotz U. Determination of ivermectin in human plasma by high-performance liquid chromatography. Arzneimittelforschung 1993;43:609-11.
28. Elkassaby M. Ivermectin uptake and distribution in the plasma and tissue of Sudanese and Mexican patients infected with Onchocerca volvulus. Trop Med Parasitol 1991;42:79-81.
29. Edwards G, Dingsdale A, Helsby N, Orme M, Breckenridge A. The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution. Eur J Clin Pharmacol 1988;35:681-4.
30. Guzzo CA, Furtek CI, Porras AG, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002;42:1122-33.
31. Kitzman D, Wei S-Y, Fleckenstein L. Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies. J Pharm Biomed Anal 2006;40:1013-20.
32. Long Q, Ren B, Li S, Zeng G. Human pharmacokinetics of orally taken ivermectin. Chin J Clin Pharmacol 2001;17:203-6.
33. Ogbuokiri JE, Ozumba BC, Okonkwo PO. Ivermectin levels in human breast milk. Eur J Clin Pharmacol 1994;46:89-90.
34. Okonkwo PO, Ogbuokiri JE, Ofoegbu E, Klotz U. Protein binding and ivermectin estimations in patients with onchocerciasis. J Clin Pharm Ther 1993;53:426-30.
35. Okell LC, Griffin JT, Kleinschmidt I, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLOS One 2011;6:e20179.
36. Cohen JM, Smith DL, Cotter C, et al. Malaria resurgence: a systematic review and assessment of its causes. Malaria J 2012;11:1-17.
37. Tiono A, Ouedraogo A, Ogutu B, et al. A controlled, parallel, clusterrandomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malaria J 2013;12:79.
38. Macauley C. Aggressive active case detection: a malaria control strategy based on the Brazilian model. Sol Sci Med 2005;60:563-73.
39. Zouré H G M, Wanji S, Noma M, et al. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLOS Negl Trop Dis 2011;5:e1210.
40. Okell LC, Bousema T, Griffin JT, Ouédraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 2012;3:1237.
41. Njenga SM, Wamae CN, Njomo DW, Mwandawiro CS, Molyneux DH. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya. Trans R Soc Trop Med Hyg 2008;102:1017-24.
42. Simonsen PE, Pedersen EM, Rwegoshora RT, Malecela MN, Derua YA, Magesa SM. Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission. PLOS Negl Trop Dis 2010;4:e696.
43. Koroma JB, Sesay S, Sonnie M, et al. Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone. PLOS Negl Trop Dis 2013;7:e2273.
44. Brown KR. Changes in the use profile 1987-1997 of Mectizan. Ann Trop Med Parasitol 1998;92:61-4.
45. Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 376:1175-85.
46. Maude R, Pontavornpinyo W, Saralamba S, et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malaria J 2009;8:31.